Sernova (TSE:SVA) Shares Up 5% – Should You Buy?

Shares of Sernova Corp. (TSE:SVA) were up 5% on Tuesday . The stock traded as high as C$0.21 and last traded at C$0.21. Approximately 48,100 shares traded hands during mid-day trading, a decline of 65% from the average daily volume of 137,715 shares. The stock had previously closed at C$0.20.

Sernova Stock Performance

The firm has a market capitalization of C$70.66 million, a P/E ratio of -2.03 and a beta of 1.35. The stock has a 50-day moving average of C$0.19 and a 200 day moving average of C$0.21. The company has a debt-to-equity ratio of -4.40, a quick ratio of 18.11 and a current ratio of 0.32.

About Sernova

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.